Universal-Beteiligungs- und Servicegesellschaft
AKRO

Universal-Beteiligungs- und Servicegesellschaft’s Akero Therapeutics AKRO Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,303
Closed -$822K – 2059
2025
Q3 		$822K Buy
17,303
+5,075
+42% +$246K ﹤0.01% 1609
2025
Q2 		$652K Buy
12,228
+792
+7% +$36K ﹤0.01% 1612
2025
Q1 		$463K Buy
+11,436
New +$485K ﹤0.01% 1668

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's AKRO Position: Q4 2025 in Review

Universal-Beteiligungs- und Servicegesellschaft sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 17,303 shares — an estimated $822K sold.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in AKRO in Q1 2025 and held it in 3 quarters. The position peaked at $822K in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Universal-Beteiligungs- und Servicegesellschaft reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Universal-Beteiligungs- und Servicegesellschaft sold 17,303 Akero Therapeutics shares in Q4 2025, an estimated $822K.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Akero Therapeutics in Q1 2025 and held it in 3 quarters.
  • Universal-Beteiligungs- und Servicegesellschaft's Akero Therapeutics position peaked at $822K in Q3 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q4 2025, filed 28 Jan 2026.